Vanda creates technological buffer zones reducing the impact of respiratory viral infections on quality of life and reducing companies’ economic losses due to disruptions in entire segments of the economy. The first zone provides the monitoring and prediction of the spread of viral respiratory infections in the surrounding area. The second zone continuously monitors the physical condition and changes in biomarkers with respect to possible exposure to a viral infection. The third zone provides disease predictions, a connection to health professionals and the escalation of healthcare.